Leading the Future of Next Generation Sequencing
Transforming Lives.
Our Mission
to bring precision medicine closer to every patient
We aim to broaden the reach of precision medicine by making Next Generation Sequencing (NGS) widely accessible to, and profitable for, small and medium sized labs.
Our Story
Foresee Genomics was founded on a singular belief: that cutting-edge genomic testing should be accessible to all.
What began as a mission to dismantle barriers is now a reality, helping transform labs worldwide. From successful pilots with leading healthcare partners to scaling globally, our journey is driven by innovation and purpose—to empower labs to lead in precision medicine and deliver life-saving results faster than ever before.

“Every lab dreams of bringing NGS in-house, but the complexity and cost make it out of reach. I knew there had to be a better way—so I built Foresee Genomics to make that vision a reality. Now, every lab can lead in precision diagnostics.”
Roi Feingersch, Founder of Foresee Genomics
Leadership Team
Foresee Genomics is spearheaded by experts in medical innovation and genomic diagnostics, with a proven track record in commercialization, dedicated to enhancing patient care through innovative NGS solutions.

Margalit Tocher, MBA
CEO
Visionary leader with a proven track record in healthcare and U.S. market expansion.

Roi Feingersch, PhD, MBA
CTO & Founder
Driving technological innovation and shaping strategic vision.

Dvir Dahary, MSc
VP of Product Development
Expert in human clinical genetics and bioinformatics